Skip to main content
OpenTrials

Clinical trial condition

Subcutaneous Emphysema

Explore clinical trials studying Subcutaneous Emphysema. Study availability and eligibility vary by location and protocol.

97 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Subcutaneous Emphysema trial results

Completed

The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency

NCT00532805

Conditions
Alpha-1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida Medical Center Gainesville, Florida, United States
  • Harvard/Brigham and Women's Hospital Boston, Massachusetts, United States
  • Cincinnati Children's Medical Center Cincinnati, Ohio, United States
View Trial Details
Completed

Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.

NCT00670007

Conditions
Alpha 1-proteinase Inhibitor Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Study Site Adelaide, South Australia, Australia
  • Study Site Fitzroy, Victoria, Australia
  • Study Site Darlinghurst, Australia
  • Study Site Nedlands, Australia
View all 21 locations
View Trial Details
Completed

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

NCT01684410

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +11 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • National Jewish Hospital Denver, Colorado, United States
  • Children's Hospital Boston Boston, Massachusetts, United States
  • UNC at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Completed

Genomic Research in Alpha-1 Antitrypsin Deficiency

NCT01832220

Conditions
AATD, Alpha 1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Arizona Health Sciences Center Tucson, Arizona, United States
  • University of California - San Francisco San Francisco, California, United States
  • National Jewish Health Denver, Colorado, United States
  • Yale University New Haven, Connecticut, United States
View Trial Details
Completed

Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency

NCT00261833

Conditions
Alpha1-Proteinase Inhibitor Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Study Site Denver, Colorado, United States
  • Study Site Miami, Florida, United States
  • Study Site Hershey, Pennsylvania, United States
  • Study Site Tyler, Texas, United States
View all 28 locations
View Trial Details

Related conditions